Philips is expanding its portfolio of nuclear medicine products by introducing a new system called BrightView XCT that should enable “low patient dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times.” The system integrates Philips BrightView SPECT “in a co-planar design with advanced flat-detector X-ray CT technology to acquire low dose, high resolution CT images and to improve registration confidence,” according to the company.
This is the first time a flat panel X-ray detector will be used for CT imaging in nuclear medicine. This system, along with the new GEMINI TF Big Bore and new NM Application Portfolio on the Extended Brilliance Workspace, is currently on display at the Society of Nuclear Medicine (SNM) annual meeting.
The BrightView XCT features technological advances that can enable low patient dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times. This offers clinical advantages particularly in cardiology studies, the top procedure in nuclear medicine. In addition, the co-planar SPECT and CT capabilities limit, and in some cases eliminate, the need to move the table between scans. Reduced movement can help improve patient comfort and allow for more confidence in image registration, the process of comparing, matching and superimposing the SPECT and CT images on one another for analysis. The BrightView XCT is also the only scalable SPECT and SPECT/CT system that fits into a 12’x15.5′ room and does not require special certification for nuclear medicine technicians.